Indeed, upon the Nurr1 knockdown by shRNA in 5xFAD, an AD mouse model, the features of AD pathology become worse, whereas the overexpression of Nurr1 (via lentiviral vector) or its pharmacological activation (amodiaquine agonist) reduce these features. Here, NR4A2 is linked to Alzheimer disease.